Jingyi Xiang
- Oncology top 5%
- Immunology top 5%
- Molecular Biology
- Biomedical Engineering
- Genetics top 10%
- Topics
- CAR-T cell therapy research (7 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Erythrocyte Function and Pathophysiology (2 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesChinaSpain
In The Last Decade
Jingyi Xiang
14 papers receiving 988 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Oncology 808
- Immunology 452
- Molecular Biology 351
- Biomedical Engineering 246
- Genetics 192
Countries citing papers authored by Jingyi Xiang
This map shows the geographic impact of Jingyi Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyi Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyi Xiang more than expected).
Fields of papers citing papers by Jingyi Xiang
This network shows the impact of papers produced by Jingyi Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyi Xiang. The network helps show where Jingyi Xiang may publish in the future.
Co-authorship network of co-authors of Jingyi Xiang
This figure shows the co-authorship network connecting the top 25 collaborators of Jingyi Xiang. A scholar is included among the top collaborators of Jingyi Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyi Xiang. Jingyi Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivobreakdown → | 628 |
| 7 | 34 | |
| 8 | 6 | |
| 9 | 34 | |
| 10 | 1 | |
| 11 | 126 | |
| 12 | 47 | |
| 13 | 41 | |
| 14 | 39 | |
| 15 | 32 | |
| 16 | Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression. | 14 |
About Jingyi Xiang
Jingyi Xiang is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Oncology (808 citations), Immunology (452 citations) and Genetics (192 citations). Jingyi Xiang has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Liu C, Su Yan, Pei Wang, Mei Song, Renier J. Brentjens, Sarwish Rafiq, Oladapo Yeku, Xiaojing Ma, Dylan J. Drakes and Dayenne G. van Leeuwen. Their work appears in journals such as Nature Communications, Blood and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.